ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 905,41
-0,26%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Biosante Pharmaceuticals (BPA)

  7. Biosante Pharmaceuticals (BPA) Actualités

BPA

Biosante Pharma (BPA)

Biosante Pharmaceuticals
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:BPA
DateHeureSourceTitreSymboleSociété
31/10/200722h21Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Amended Securities Registration (section 12(b)) (8-A12B/A)AMEX:BPABiosante Pharmaceuticals
24/10/200717h23Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filing (8-K)AMEX:BPABiosante Pharmaceuticals
24/10/200717h23Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filingAMEX:BPABiosante Pharmaceuticals
24/09/200719h57PR Newswire (US)WallSt.net Announces Upcoming Interview with CEO of BioSante PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
14/08/200722h15Business WireBioSante Pharmaceuticals Reports Second Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
08/08/200714h00Business WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
25/07/200714h00Business WireBioSante Pharmaceuticals Announces Positive Results for its CaP Technology for Use in Aesthetic MedicineAMEX:BPABiosante Pharmaceuticals
11/07/200714h00Business WireBioSante Pharmaceuticals Announces New Findings for Potential Bird Flu VaccineAMEX:BPABiosante Pharmaceuticals
10/07/200713h00PR Newswire (US)WallSt.net (www.wallst.net ) Updates the Investment Community Through All-New Interviews with BPA, PPCO and NVAXAMEX:BPABiosante Pharmaceuticals
28/06/200713h00Business WireBioSante Pharmaceuticals, Inc. Joins Russell Microcap IndexAMEX:BPABiosante Pharmaceuticals
19/06/200714h00Business WireBioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study InitiationAMEX:BPABiosante Pharmaceuticals
14/06/200714h00Business WireBioSante Pharmaceuticals Completes $18.3 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
13/06/200714h45PR Newswire (US)Bradley Pharmaceuticals Announces Launch of Elestrin(TM)AMEX:BPABiosante Pharmaceuticals
25/05/200715h26Business WireBioSante Pharmaceuticals Announces $16.5 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
07/05/200714h00Business WireBioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei BioscienceAMEX:BPABiosante Pharmaceuticals
04/05/200714h45PR Newswire (US)Bradley Pharmaceuticals to Preview New Products at ACOG MeetingAMEX:BPABiosante Pharmaceuticals
01/05/200723h00Business WireBioSante Pharmaceuticals Reports First Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
11/04/200714h45PR Newswire (US)Bradley Pharmaceuticals' Elestrin(TM) Receives New Patent to 2022AMEX:BPABiosante Pharmaceuticals
10/04/200714h00Business WireBioSante Pharmaceuticals Announces Issuance of New Patent Covering Elestrin(TM) and LibiGel(R)AMEX:BPABiosante Pharmaceuticals
02/04/200720h09PR Newswire (US)Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price TargetAMEX:BPABiosante Pharmaceuticals
26/03/200713h30Business WireBioSante Pharmaceuticals Receives Milestone Payment from Bradley PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
08/03/200722h34Business WireBioSante Pharmaceuticals Reports Net Profit of $2.8 million for 2006 And Investor Conference CallAMEX:BPABiosante Pharmaceuticals
30/01/200714h00Business WireBioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical StudyAMEX:BPABiosante Pharmaceuticals
16/01/200715h00Business WireStephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc., Talks to The Wall Street TranscriptAMEX:BPABiosante Pharmaceuticals
19/12/200613h45PR Newswire (US)Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)AMEX:BPABiosante Pharmaceuticals
04/12/200614h00Business WireBioSante Pharmaceuticals to Present at Upcoming Biotech/Specialty Pharma and Investor ConferencesAMEX:BPABiosante Pharmaceuticals
14/11/200614h00Business WireBioSante Pharmaceuticals Reports Third Quarter 2006 Financial Results And Reviews Bio-E-Gel(R) Marketing AgreementAMEX:BPABiosante Pharmaceuticals
08/11/200613h45Business WireBioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.AMEX:BPABiosante Pharmaceuticals
08/11/200613h45PR Newswire (US)Bradley Pharmaceuticals Enters Into Agreement With BioSante Pharmaceuticals for Estradiol Transdermal GelAMEX:BPABiosante Pharmaceuticals
03/11/200614h00Business WireBioSante Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare ConferenceAMEX:BPABiosante Pharmaceuticals
 Showing the most relevant articles for your search:AMEX:BPA

Dernières Valeurs Consultées

COIN
COSMKRW
CosmoCoin
LBNK
STABTC
STA
COIN
UOSKRW
Ultra Token
USOTC
RSARS
RSE Collection (GM)
ASX
WLCNA
ASX
GTERD
Great Western Exploration
DBI
I1P9
Xtr MSCI EM Latin Americ...
LSE
AB24
BIT
OMER
Omer
BIT
P16K04
BNP Paribas Issuance
TSXV
CMO.H
Cliffmont Resources
USOTC
AIQUY
L Air Liquide (PK)
NASDAQ
VERX
Vertex
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés